Kevzara (sarilumab)

pCPA File Number: 21047
Negotiation Status:
Concluded with an LOI
Indication(s):
Subacute and chronic inflammatory joint diseases
Sponsor/Manufacturer:
Sanofi-aventis Canada Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: